0001850995-22-000001.txt : 20220608 0001850995-22-000001.hdr.sgml : 20220608 20220608154615 ACCESSION NUMBER: 0001850995-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220608 DATE AS OF CHANGE: 20220608 EFFECTIVENESS DATE: 20220608 FILER: COMPANY DATA: COMPANY CONFORMED NAME: U1 Bio, Inc. CENTRAL INDEX KEY: 0001850995 IRS NUMBER: 861521313 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-448526 FILM NUMBER: 221003419 BUSINESS ADDRESS: STREET 1: 18 BARTOL STREET #966 CITY: SAN FRANCISCO STATE: CA ZIP: 94133 BUSINESS PHONE: (336) 420-7881 MAIL ADDRESS: STREET 1: 18 BARTOL STREET #966 CITY: SAN FRANCISCO STATE: CA ZIP: 94133 D 1 primary_doc.xml X0708 D LIVE 0001850995 U1 Bio, Inc. 18 BARTOL STREET #966 SAN FRANCISCO CA CALIFORNIA 94133 (336) 420-7881 DELAWARE None None Corporation true 2021 David Nelles 18 Bartol Street #966 San Francisco CA CALIFORNIA 94133 Executive Officer Director Director and CEO Konstantinos Charizanis 18 Bartol Street #966 San Francisco CA CALIFORNIA 94133 Executive Officer Director Director and COO Sharam Seyedin-Noor 19 Cecilia Court Belvedere Tiburon CA CALIFORNIA 94920 Director Biotechnology Decline to Disclose 06b false 2022-05-31 false true false 25000 10650000 9498000 1152000 $650,000 of the Total Offering Amount results from the conversion of SAFEs, so the amount of new money in the Offering is $10,000,000 false 26 0 0 0 Proceeds to be used for working capital false U1 Bio, Inc. David Nelles David Nelles CEO 2022-06-08